Replies to post #167724 on Cytodyn Inc (CYDY)

[Bill_ENG]

He is not mistaken, that is the treatment protocol for the 594 patient moderate trial.

Yup, they are doing a phase 3 that follows the patient population that benefitted most in CD10.

NP covering all bases.

Lot of potential here.